HIGHLIGHTS
- who: Li-Ting Shen from the (UNIVERSITY) have published the article: Aberrant RNA m6A modification in gastrointestinal malignancies: versatile regulators of cancer hallmarks and novel therapeutic opportunities, in the Journal: (JOURNAL) of 15/Dec/2022
- future: Considering the complexity of the TIME future studies should focus on the heterogeneity as well as the potential communication of the m6A modification between different components in the TIME. On another note while studies are lacking assessing m6A regulated B cell dysregulation in TIME B cells in the germinal center of a non-tumor model are tightly controlled by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.